In their quest to treat cardiovascular disease, researchers have been interested in developing new medicines that activate a protein called APJ. Medical researchers have now uncovered another function for APJ — it senses mechanical changes that set the body on a course toward heart failure. This means activating APJ could be harmful in some cases — potentially eye-opening information for some drug makers.